Stock Evaluator: Alfresa Holdings Corporation (ALFRY)
Alfresa Holdings Corporation ALFRY
$13.55
0.00
0.00%
July 15, 2026 2:29:00 PM
EST
Volume: 0
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.
Financial Summary
| Share Statistics | ALFRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,560.3 | $1,875.0 | 57% |
|
| Shares Out (Mil) | 1.1 | 77.1 | 5% |
|
| Institutional Ownership | 96.0% | 88.9% | 69% |
|
| Float (Mil) | 149.0 | 50.3 | 69% |
|
| Beta | -0.16 | 0.86 | 4% |
|
| Avg Daily Volume (000s) | 1 | 466 | 4% |
|
| Price Change (52-week) |
na | 78.5% | na |
|
| Growth | ALFRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (3.7%) | 10.9% | 10% |
|
| Net Income (5yr) | 3.5% | (1.1%) | 45% |
|
| EPS (5yr) | 6.6% | 3.0% | 40 |
|
| Dividends (5yr) | (2.2%) | 0.0% | 67% |
|
| Cash Flow (5yr) | 19.7% | (18.2%) | 79% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ALFRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $19,522 | $1,464 | 91% |
|
| Net Income (TTM) (Mil) | $263 | $15 | 71% |
|
| EPS (TTM) | $1.444 | $0.300 | 66% |
|
| Operating Cash Flow (TTM) (Mil) | na | $138 | na |
|
| Net Cash Flow (TTM) (Mil) | na | $7 | na |
|
| Long-Term Debt (Q1) (Mil) | $213 | $323 | 51% |
|
| Enterprise Value (Q1) (Mil) | $1,469 | $2,130 | 46% |
|
| Valuation | ALFRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.90 | na |
|
| P/E | na | 26.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | ALFRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 7.0% | 27.6% | 7% |
|
| Net Margin | 1.3% | 1.1% | 36% |
|
| ROA | 2.8% | 1.8% | 61% |
|
| ROE | 8.3% | 6.9% | 52% |
|
| Liabilities to Assets | 66.3% | 60.0% | 61% |
|
| F-Score | na | 5 | na |
|
Alfresa Holdings Corporation did not pass any screens on 7/30/2026.
